E-cadherin/α-catenin deregulated co-expression in thyroid carcinoma based on tissue microarray digital image analysis

Area of Science:

• Oncology
• Molecular Biology
• Cell Adhesion

Background:

• Cell-to-cell adhesion molecule deregulation is critical in epithelial malignancies, increasing metastatic potential.
• E-cadherin and catenins, particularly α and β, function as oncogenes in carcinogenesis, influencing signaling pathways like Wnt/β-catenin.
• Reduced expression of these proteins in thyroid carcinoma is linked to increased tumor aggressiveness.

Purpose of the Study:

• To investigate the deregulation of the e-cadherin/α-catenin complex in thyroid carcinomas.
• To correlate protein expression levels with clinicopathological features of thyroid neoplasms.

Main Methods:

• Utilized immunohistochemistry (IHC) on a tissue microarray of 35 samples (20 thyroid carcinomas, 15 benign nodules).
• Employed anti-e-cadherin/α-catenin antibodies for protein expression analysis.
• Implemented digital image analysis to quantify protein expression levels.

Main Results:

• A significant progressive decrease in e-cadherin/α-catenin expression was observed from benign to malignant lesions (p=0.001).
• Fifty percent of thyroid cancer cases (10/20) showed reduced or lost expression, correlating with advanced stage and nodal metastasis (p=0.02).
• Combined loss of expression was associated with follicular and anaplastic histology (p=0.001), and α-catenin expression correlated with differentiation grade (p=0.01).

Conclusions:

• Progressive loss of e-cadherin and α-catenin expression is associated with an aggressive thyroid carcinoma phenotype, including poor differentiation and increased metastatic activity.
• Aberrant protein expression patterns highlight potential therapeutic targets for novel agents aimed at restoring normal function.